SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-016494
Filing Date
2023-05-08
Accepted
2023-05-08 17:15:39
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20230331.htm   iXBRL 10-Q 1057521
2 EX-31.1 xncr-20230331xexx311.htm EX-31.1 10318
3 EX-31.2 xncr-20230331xexx312.htm EX-31.2 10140
4 EX-32.1 xncr-20230331xexx321.htm EX-32.1 6479
  Complete submission text file 0001628280-23-016494.txt   5619276

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20230331.xsd EX-101.SCH 35441
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20230331_cal.xml EX-101.CAL 62558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20230331_def.xml EX-101.DEF 198039
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20230331_lab.xml EX-101.LAB 513869
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20230331_pre.xml EX-101.PRE 344287
54 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20230331_htm.xml XML 932702
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 23898902
SIC: 2834 Pharmaceutical Preparations